Explore the words cloud of the C.A.R.E. OA project. It provides you a very rough idea of what is the project "C.A.R.E. OA" about.
The following table provides information about the project.
|Coordinator Country||Sweden [SE]|
|Total cost||203˙852 €|
|EC max contribution||203˙852 € (100%)|
1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
|Duration (year-month-day)||from 2021-03-01 to 2023-02-28|
Take a look of project's partnership.
|1||GOETEBORGS UNIVERSITET||SE (GOETEBORG)||coordinator||203˙852.00|
The purpose of this project is to define how estrogen- and adenosine-receptors modulate each other in CD4 T-cells during osteoarthritis (OA) development and how these pathways can be targeted for development of a new OA therapy. Alterations of the articular cartilage function and of the joint surrounding tissues lead to disease like OA. OA is a chronic invalidating disease with a large social impact. There is no cure and the treatments to manage symptoms, pharmacological and non-pharmacological therapies, are useful only for a limited time, after which joint replacement surgery is necessary. Women have increased risk of developing OA compared to men and epidemiology studies suggest that hormonal alterations play an important role in OA development. It is now widely recognized that inflammation is an important disease mechanism in OA pathogenesis. In particular CD4 T cells have been identified as triggers of cartilage degradation in OA. CD4 T cells express estrogen- and adenosine receptors, two important regulators of the immune system. In a recently published article, I showed that female mice lacking one of the adenosine receptors, A2A (A2AR), develop spontaneous OA with significantly milder disease symptoms compared to males suggesting a protective effect of female sex hormones on OA development. Interestingly, it has been shown that estrogens can modulate the expression of adenosine receptors. In this project, I am going to investigate the effect of pharmacological activation of estrogen receptors on the anti-inflammatory A2AR and the pro-inflammatory A2BR, and the involvement of their mutual interaction on CD4 T cell proliferation, differentiation and migration ability. Moreover, the effect of combined A2B adenosine receptor blocking and estrogen treatment will be tested as a strategy for reducing pain and disease progression in an OA mouse model.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "C.A.R.E. OA" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "C.A.R.E. OA" are provided by the European Opendata Portal: CORDIS opendata.
New treatments and novel diagnostic tests for neonatal seizures based on purinergic signaling.Read More
Multi-color and single-molecule fluorescence imaging of intraflagellar transport in the phasmid chemosensory cilia of C. ElegansRead More
Shaping the European Migration Policy: the role of the security industryRead More